Strategies of pain reduction during the bone marrow biopsy Nikolaj HjortholmEmil JaddiniEmilian Snarski Review Article Open access 06 December 2012 Pages: 145 - 149
Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K–562 with unmodified or chemically modified siRNAs and induction of apoptosis Burçin Tezcanlı KaymazNur SelviBuket Kosova Original Article 04 October 2012 Pages: 151 - 162
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement Hee-Jin KimHee Kyung Ahnon behalf of AML/MDS working party, Korean Society of Hematology Original Article 28 September 2012 Pages: 163 - 171
Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia Elisabeth Oppliger LeibundgutNaomi A. PorretGabriela M. Baerlocher Original Article 17 November 2012 Pages: 173 - 177
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia Mario TiribelliRoberto LatagliataPaolo Vigneri Original Article 10 October 2012 Pages: 179 - 183
Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome Dayane B. KoshiyamaMarcelo E. Z. CapraPaulo R. G. Zen Original Article 14 October 2012 Pages: 185 - 189
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload F. NolteB. HöchsmannH. Schrezenmeier Original Article 17 October 2012 Pages: 191 - 198
Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome Hong WangRong FanWei-Yang Li Original Article 24 October 2012 Pages: 199 - 209
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy J. B. PorterM. S. ElalfyA. El-Beshlawy Original Article Open access 21 October 2012 Pages: 211 - 219
Effect of different doses of iron supplementation during pregnancy on maternal and infant health Blanca RibotNúria ArandaVictoria Arija Original Article 04 October 2012 Pages: 221 - 229
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy Tark KimSang-Ho ChoiSang-Oh Lee Original Article 10 October 2012 Pages: 231 - 238
Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma Yukihiro MiyazakiYuichiro NawaMasamichi Hara Original Article Open access 19 October 2012 Pages: 239 - 244
Multiple angiogenetic factors are upregulated in POEMS syndrome Yuta YamadaSetsu SawaiSatoshi Kuwabara Original Article 06 October 2012 Pages: 245 - 248
Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia Marta KrejciMichael DoubekJiri Mayer Original Article 27 September 2012 Pages: 249 - 254
Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation Kumi OshimaYoshinobu Kandafor the Kanto Study Group for Cell Therapy (KSGCT) Original Article 04 October 2012 Pages: 255 - 260
Prevalence of factor V G1691A, factor II G20210A, methylenetetrahydrofolate reaductase C677T and endothelial protein C receptor 23 bp insertion polymorphisms in indigenous population of Nepal Anita PatilBishesh Sharma PoudyalShrimati Shetty Letter to the Editor 11 August 2012 Pages: 261 - 262
Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience Vlachaki EfthimiaNikolaos NeokleousVasileios Perifanis Letter to the Editor 30 August 2012 Pages: 263 - 265
Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine Yu-Yan HwangPo TsuiYok-Lam Kwong Letter to the Editor Open access 19 August 2012 Pages: 267 - 268
Lung involvement at initial presentation in blastic plasmacytoid dendritic cell neoplasm lacking cutaneous lesion Koji EndoKeichiro MiharaYoshihiro Takihara Letter to the Editor 30 August 2012 Pages: 269 - 270
Renal failure secondary to leukemic infiltration of kidneys in CLL—a case report and review of literature Dipesh UpretyAlan PetersonBinay Kumar Shah Letter to the Editor 09 August 2012 Pages: 271 - 273
Intravascular large B cell lymphoma presenting as anasarca: an unusual presentation of a rare lymphoma Narat SrivaliKunatum PrasidthratsintPatompong Ungprasert Letter to the Editor 25 August 2012 Pages: 275 - 276
Symmetric multifocal bone marrow involvement diagnosed by whole-body magnetic resonance imaging in a patient with B lymphoblastic lymphoma Ruth EichnerKlaus WörtlerKatharina Götze Letter to the Editor 19 August 2012 Pages: 277 - 278
Primary effusion anaplastic large cell lymphoma in a patient with long-standing dermatitis herpetiformis and celiac disease Mehdi NassiriMichael J. RobertsonMagdalena B. Czader Letter to the Editor 23 August 2012 Pages: 279 - 281
Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate Gang Cheng Letter to the Editor 11 August 2012 Pages: 283 - 284
A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult Hamid ShaabanJoan DabuGunwant Guron Letter to the Editor 02 September 2012 Pages: 285 - 286
No evidence of hemostasis disturbance in Thai children with iron deficiency anemia Nongnuch SirachainanPornchanok IamsirirakPimlak Charoenkwan Letter to the Editor 09 September 2012 Pages: 287 - 288
